ADIAL PHARMACEUTICALS INC COM NEW

ADIAL PHARMACEUTICALS INC COM NEW is a security (CUSIP 00688A304) tracked across SEC portfolio filings. 13 institutional managers reported $73K on Form 13F as of 2026-06-30; 2 registered fund positions totaling $644 via N-PORT as of 2026-03-31.

Summary

Top institutional holders (Form 13F)

ManagerLocationValueShares
GEODE CAPITAL MANAGEMENT, LLCBOSTON, MA$43K24,249
China Universal Asset Management Co., Ltd.SHANGHAI, F4$20K8,000
Manchester Capital Management LLCMANCHESTER, VT$3K1,923
Tower Research Capital LLC (TRC)NEW YORK, NY$2K1,356
BlackRock, Inc.New York, NY$2K1,110
UBS Group AGZurich, V8$970542
RAFFA WEALTH MANAGEMENT, LLCWASHINGTON, DC$21283
SBI Securities Co., Ltd.TOKYO, M0$12047
MORGAN STANLEYNEW YORK, NY$9050
WELLS FARGO & COMPANY/MNSAN FRANCISCO, CA$116
NORTHWESTERN MUTUAL WEALTH MANAGEMENT COMILWAUKEE, WI$74
HARBOUR INVESTMENTS, INC.MADISON, WI$53
Abound Wealth ManagementFRANKLIN, TN$31

Top fund holders (N-PORT)

FundRegistrantValue% of fund
VANGUARD EXTENDED MARKET INDEX FUNDVANGUARD INDEX FUNDS$6460.00%
Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Funds$-2-0.00%

More